Patents by Inventor John T. Catlow

John T. Catlow has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Indazolecarboxamides
    Patent number: 5817676
    Abstract: Indazolecarboxamides are used as antagonists and partial agonists for the serotonin receptor 5-HT.sub.4 and provide therapeutic methods for treatment of disorders caused by or affected by dysfunction of the 5-HT.sub.4 receptor.
    Type: Grant
    Filed: January 10, 1997
    Date of Patent: October 6, 1998
    Assignee: Eli Lilly and Company
    Inventors: John T. Catlow, Marlene L. Cohen, Michael O. Martinelli, John M. Schaus, Steven Swanson, Dennis C. Thompson, Thomas M. Wilson
  • Indazolecarboxamides
    Patent number: 5798367
    Abstract: Indazolecarboxamides are used as antagonists and partial agonists for the serotonin receptor 5-HT.sub.4 and provide therapeutic methods for treatment of disorders caused by or affected by dysfunction of the 5-HT.sub.4 receptor.
    Type: Grant
    Filed: January 10, 1997
    Date of Patent: August 25, 1998
    Assignee: Eli Lilly and Company
    Inventors: John T. Catlow, Marlene L. Cohen, Michael J. Martinelli, John M. Schaus, Steven Swanson, Dennis C. Thompson, Thomas M. Wilson
  • Indazolecarboxamides
    Patent number: 5654320
    Abstract: Indazolecarboxamides are used as antagonists and partial agonists for the serotonin receptor 5-HT.sub.4 and provide therapeutic methods for treatment of disorders caused by or affected by dysfunction of the 5-HT.sub.4 receptor.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: August 5, 1997
    Assignee: Eli Lilly and Company
    Inventors: John T. Catlow, Michael J. Martinelli, John M. Schaus, Steven Swanson, Dennis C. Thompson